Wednesday, May 22, 2013

• Life Science Industry Veteran Stephane Bancel Joins Flagship VenturesPR Newswire( (Wed 8:38AM EDT)

Friday, May 10, 2013

• BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire( (Fri, May 10)

Thursday, May 9, 2013

• BG Medicine Appoints Dr. Paul Sohmer as Chief Executive OfficerGlobeNewswire( (Thu, May 9)
• BG Medicine Reports 2013 First Quarter Financial ResultsGlobeNewswire( (Thu, May 9)

Wednesday, May 8, 2013

• Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital ReadmissionsGlobeNewswire( (Wed, May 8)

Thursday, May 2, 2013

• BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013GlobeNewswire( (Thu, May 2)

Wednesday, April 10, 2013

• BG Medicine Welcomes CE Mark for Galectin-3 TestGlobeNewswire( (Wed, Apr 10)
• Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure PatientsPR Newswire( (Wed, Apr 10)

Thursday, March 14, 2013

• Boeing Gets Target Price Lift to $100 with 787 Closer to Being Fixed. Futures Show Sign Of A Bullish OpenAccesswire( (Thu, Mar 14)

Wednesday, March 13, 2013

• BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 OutlookGlobeNewswire( (Wed, Mar 13)

Wednesday, March 6, 2013

• BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & ExpoGlobeNewswire( (Wed, Mar 6)
• BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013GlobeNewswire( (Wed, Mar 6)